A Study of Odanacatib When Administered to Adolescents and Young Adults Treated With Glucocorticoids (MK-0822-066)
Clinical trial NCT01630616 · TERMINATED
Trial details
- NCT number
- NCT01630616
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-12
- Primary completion
- 2016-07-14
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.